Production (Stage)
Artelo Biosciences, Inc.
ARTL
$0.9527
-$0.0023-0.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -5.42% | -2.81% | -19.99% | -21.36% | -23.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.22% | 1.79% | -6.20% | 10.14% | -3.82% |
| Operating Income | 3.22% | -1.79% | 6.20% | -10.14% | 3.82% |
| Income Before Tax | -1.16% | -5.78% | 4.54% | -10.62% | 6.63% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.16% | -5.78% | 4.54% | -10.62% | 6.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.16% | -5.78% | 4.54% | -10.62% | 6.63% |
| EBIT | 3.22% | -1.79% | 6.20% | -10.14% | 3.82% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 4.63% | 2.37% | 14.43% | -0.37% | 13.45% |
| Normalized Basic EPS | 8.89% | 6.08% | 15.91% | 0.08% | 10.80% |
| EPS Diluted | 4.73% | 2.29% | 14.36% | -0.44% | 13.38% |
| Normalized Diluted EPS | 8.89% | 6.08% | 15.91% | 0.08% | 10.80% |
| Average Basic Shares Outstanding | 6.64% | 9.00% | 11.64% | 10.17% | 7.15% |
| Average Diluted Shares Outstanding | 6.64% | 9.00% | 11.64% | 10.17% | 7.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |